Evidence map›Paper›PMID 36293226›Full record

ArticleInternational journal of molecular sciences2022

Characterization of the Human Papillomavirus 16 Oncogenes in K14HPV16 Mice: Sublineage A1 Drives Multi-Organ Carcinogenesis.

Daniela Cochicho, Alexandra Nunes, João Paulo Gomes, Luís Martins, Mário Cunha, Beatriz Medeiros-Fonseca, Paula Oliveira, Margarida M S M Bastos, Rui Medeiros, Joana Mendonça and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. The Effect of Lemon Juice (Antioxidants (Basel, Switzerland) · 2024
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Daniela CochichoNOVA Medical School-Universidade NOVA de Lisboa, NOVA University, 1169-056 Lisbon, Portugal.
Alexandra NunesGenomics and Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Dr. Ricardo Jorge (INSA), 1649-016 Lisbon, Portugal.ORCID 0000-0001-6449-8053
João Paulo GomesGenomics and Bioinformatics Unit, Department of Infectious Diseases, National Institute of Health Dr. Ricardo Jorge (INSA), 1649-016 Lisbon, Portugal.ORCID 0000-0002-2697-2399
Luís MartinsVirology Laboratory from Clinical Pathology Department, Portuguese Institute of Oncology Francisco Gentil (IPOLFG), 1099-023 Lisbon, Portugal.ORCID 0000-0002-6888-4477
Mário CunhaVirology Laboratory from Clinical Pathology Department, Portuguese Institute of Oncology Francisco Gentil (IPOLFG), 1099-023 Lisbon, Portugal.ORCID 0000-0002-9910-9035
Beatriz Medeiros-FonsecaCentre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), Inov4Agro, University of Trás-os-Montes e Alto Douro (UTAD), Quinta de Prados, 5000-801 Vila Real, Portugal.ORCID 0000-0002-3909-5903
Paula OliveiraCentre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), Inov4Agro, University of Trás-os-Montes e Alto Douro (UTAD), Quinta de Prados, 5000-801 Vila Real, Portugal.ORCID 0000-0001-9519-4044
Margarida M S M BastosLaboratory for Process Engineering, Environment, Biotechnology and Energy (LEPABE), Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal.ORCID 0000-0002-8605-0054
Rui MedeirosLaboratory for Process Engineering, Environment, Biotechnology and Energy (LEPABE), Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal.
Joana MendonçaTechnology and Innovation Unit, Department of Human Genetics, National Institute of Health, Av. Padre Cruz (INSA), 1649-016 Lisbon, Portugal.
Luis VieiraTechnology and Innovation Unit, Department of Human Genetics, National Institute of Health, Av. Padre Cruz (INSA), 1649-016 Lisbon, Portugal.
Rui M Gil da CostaCentre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), Inov4Agro, University of Trás-os-Montes e Alto Douro (UTAD), Quinta de Prados, 5000-801 Vila Real, Portugal.ORCID 0000-0002-2151-2449
Ana FelixNOVA Medical School-Universidade NOVA de Lisboa, NOVA University, 1169-056 Lisbon, Portugal.ORCID 0000-0002-2653-2262
Instituto Português de Oncologia Francisco Gentil · PTNational Institute of Health Dr. Ricardo Jorge · PTUniversity of Trás-os-Montes and Alto Douro · PTUniversidade do Porto · PT

Funding

COMPETE 2020 - Operational Programme for Competitiveness and Internationalisation (POCI) POCI-01-0145-FEDER-022184iNOVA4Health UIDB/04462/2020 and UIDP/04462/2020
6 · The paper itself

Abstract

The study of human papillomavirus (HPV)-induced carcinogenesis uses multiple in vivo mouse models, one of which relies on the cytokeratin 14 gene promoter to drive the expression of all HPV early oncogenes. This study aimed to determine the HPV16 variant and sublineage present in the K14HPV16 mouse model. This information can be considered of great importance to further enhance this K14HPV16 model as an essential research tool and optimize its use for basic and translational studies. Our study evaluated HPV DNA from 17 samples isolated from 4 animals, both wild-type (n = 2) and HPV16-transgenic mice (n = 2). Total DNA was extracted from tissues and the detection of HPV16 was performed using a qPCR multiplex. HPV16-positive samples were subsequently whole-genome sequenced by next-generation sequencing techniques. The phylogenetic positioning clearly shows K14HPV16 samples clustering together in the sub-lineage A1 (NC001526.4). A comparative genome analysis of K14HPV16 samples revealed three mutations to the human papillomaviruses type 16 sublineage A1 representative strain. Knowledge of the HPV 16 variant is fundamental, and these findings will allow the rational use of this animal model to explore the role of the A1 sublineage in HPV-driven cancer.

Indexed as

Papillomavirus InfectionsUterine Cervical NeoplasmsAnimalsCarcinogenesisFemaleHuman papillomavirus 16HumansKeratin-14MiceOncogenesPapillomaviridaePhylogenyKeratin-14carcinogenesisHPV16K14HPV16lineagevariant

Identifiers

PMID36293226
PMCPMC9604181
OpenAlexW4306385397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.